Payment overview · 2025
General Payments
$839.08
19 reported records · 6 companies
Healthcare provider profile · identity verified
Snehal Patel, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · YORK, PA · NPI 1629038393
Verified facts
What the public records show
CMS Open Payments records show Snehal Patel, M.D. received $839.08 in general payments during 2025 across 19 reported records.
Novo Nordisk Inc accounted for 48.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 60 claims for Synthroid by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 491 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 76 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $409.48 | 48.8% | 11 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $125.00 | 14.9% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $93.92 | 11.2% | 2 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $72.36 | 8.6% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $69.21 | 8.2% | 3 | 2025 |
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $69.11 | 8.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $839.08 | 19 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $409.48 | 11 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $245.53 | 8 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $73.86 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $72.36 | 1 | 2025 |
Source payment records
|
|||||
| DUPIXENT Normalized: dupixent |
Biological | Regeneron Healthcare Solutions, Inc. | $69.11 | 1 | 2025 |
Source payment records
|
|||||
| AMPLATZER Normalized: amplatzer |
Device | Abbott Laboratories | $32.32 | 1 | 2025 |
Source payment records
|
|||||
| CARDIOMEMS Normalized: cardiomems |
Device | Abbott Laboratories | $23.07 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $20.06 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $20.06 | 1 | 2025 |
Source payment records
|
|||||
| THORATEC HEARTMATE 3 LVAS IMPLANT KIT Normalized: thoratec heartmate 3 lvas implant kit |
Device | Abbott Laboratories | $13.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 76 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
39 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
35 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
60 | 19 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
491 | 71 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
97 | 15 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
76 | 23 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3170 | 503 |
| Furosemide | Furosemide | 2276 | 193 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1952 | 211 |
| Omeprazole | Omeprazole | 1923 | 200 |
| Gabapentin | Gabapentin | 1543 | 127 |
| Amlodipine Besylate | Amlodipine Besylate | 1461 | 204 |
| Lisinopril | Lisinopril | 1419 | 243 |
| Metoprolol Succinate | Metoprolol Succinate | 1357 | 179 |
| Eliquis | Apixaban | 1292 | 98 |
| Sertraline Hcl | Sertraline Hcl | 1236 | 82 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1043 | 78 |
| Simvastatin | Simvastatin | 1021 | 154 |
| Tamsulosin Hcl | Tamsulosin Hcl | 917 | 97 |
| Potassium Chloride | Potassium Chloride | 901 | 70 |
| Trazodone Hcl | Trazodone Hcl | 896 | 108 |
| Pantoprazole Sodium | Pantoprazole Sodium | 871 | 142 |
| Metoprolol Tartrate | Metoprolol Tartrate | 744 | 82 |
| Metformin Hcl | Metformin Hcl | 683 | 133 |
| Losartan Potassium | Losartan Potassium | 609 | 93 |
| Clopidogrel | Clopidogrel Bisulfate | 578 | 57 |
| Carvedilol | Carvedilol | 570 | 56 |
| Donepezil Hcl | Donepezil Hcl | 570 | 42 |
| Mirtazapine | Mirtazapine | 550 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 522 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 520 | 36 |
| Jardiance | Empagliflozin | 491 | 71 |
| Finasteride | Finasteride | 470 | 43 |
| Fluoxetine Hcl | Fluoxetine Hcl | 455 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 435 | 88 |
| Baclofen | Baclofen | 403 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 363 | 44 |
| Allopurinol | Allopurinol | 361 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 338 | 64 |
| Buspirone Hcl | Buspirone Hcl | 336 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 332 | 35 |
| Prednisone | Prednisone | 318 | 183 |
| Famotidine | Famotidine | 312 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 305 | 24 |
| Risperidone | Risperidone | 279 | 17 |
| Atenolol | Atenolol | 266 | 48 |
| Olanzapine | Olanzapine | 260 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 250 | 89 |
| Ezetimibe | Ezetimibe | 247 | 28 |
| Bumetanide | Bumetanide | 240 | 12 |
| Lorazepam | Lorazepam | 232 | 65 |
| Glipizide Er | Glipizide | 231 | 55 |
| Spironolactone | Spironolactone | 231 | 26 |
| Paroxetine Hcl | Paroxetine Hcl | 225 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 223 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 210 | 44 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 206 | 58 |
| Metformin Hcl Er | Metformin Hcl | 202 | 28 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 196 | 42 |
| Primidone | Primidone | 175 | suppressed |
| Levetiracetam | Levetiracetam | 170 | 18 |
| Alendronate Sodium | Alendronate Sodium | 167 | 20 |
| Trimethoprim | Trimethoprim | 166 | suppressed |
| Meloxicam | Meloxicam | 165 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 163 | 68 |
| Divalproex Sodium Er | Divalproex Sodium | 159 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 158 | 11 |
| Myrbetriq | Mirabegron | 158 | suppressed |
| Memantine Hcl | Memantine Hcl | 154 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 154 | 27 |
| Tramadol Hcl | Tramadol Hcl | 152 | 35 |
| Topiramate | Topiramate | 148 | suppressed |
| Lovastatin | Lovastatin | 138 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 137 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 134 | 27 |
| Xarelto | Rivaroxaban | 131 | 18 |
| Aripiprazole | Aripiprazole | 130 | suppressed |
| Digoxin | Digoxin | 130 | suppressed |
| Glipizide | Glipizide | 126 | 28 |
| Montelukast Sodium | Montelukast Sodium | 126 | 17 |
| Bupropion Xl | Bupropion Hcl | 125 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 125 | 54 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 121 | 19 |
| Methenamine Hippurate | Methenamine Hippurate | 117 | suppressed |
| Valsartan | Valsartan | 115 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 113 | 16 |
| Lamotrigine | Lamotrigine | 112 | suppressed |
| Lansoprazole | Lansoprazole | 112 | suppressed |
| Nifedipine Er | Nifedipine | 110 | suppressed |
| Azithromycin | Azithromycin | 108 | 85 |
| Warfarin Sodium | Warfarin Sodium | 108 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 99 | 49 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 98 | 26 |
| Sucralfate | Sucralfate | 97 | suppressed |
| Trulicity | Dulaglutide | 97 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 96 | 30 |
| Nystatin | Nystatin | 94 | 40 |
| Enalapril Maleate | Enalapril Maleate | 92 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 91 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 90 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 90 | 12 |
| Midodrine Hcl | Midodrine Hcl | 89 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 87 | suppressed |
| Alprazolam | Alprazolam | 81 | 18 |
| Carbamazepine | Carbamazepine | 80 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 80 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 78 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 78 | 45 |
| Ozempic | Semaglutide | 76 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 75 | 18 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 75 | suppressed |
| Torsemide | Torsemide | 75 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 75 | 16 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 73 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 73 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 73 | 13 |
| Latanoprost | Latanoprost | 71 | 12 |
| Fenofibrate | Fenofibrate | 70 | 12 |
| Terazosin Hcl | Terazosin Hcl | 70 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 69 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 69 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 66 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 66 | 13 |
| Tolterodine Tartrate | Tolterodine Tartrate | 63 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 62 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 61 | 35 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 61 | suppressed |
| Synthroid | Levothyroxine Sodium | 60 | 19 |
| Lidocaine | Lidocaine | 59 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 58 | suppressed |
| Gemfibrozil | Gemfibrozil | 57 | suppressed |
| Entresto | Sacubitril/Valsartan | 55 | suppressed |
| Ketoconazole | Ketoconazole | 55 | 16 |
| Carbamazepine Er | Carbamazepine | 54 | suppressed |
| Naproxen | Naproxen | 54 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | 13 |
| Acarbose | Acarbose | 52 | suppressed |
| Clonazepam | Clonazepam | 52 | 12 |
| Febuxostat | Febuxostat | 52 | suppressed |
| Perphenazine | Perphenazine | 52 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 52 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 51 | suppressed |
| Calcitriol | Calcitriol | 51 | suppressed |
| Amoxicillin | Amoxicillin | 50 | 32 |
| Fenofibrate | Fenofibrate,micronized | 49 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | suppressed |
| Ondansetron Odt | Ondansetron | 47 | 38 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 46 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 46 | 32 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 45 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 44 | suppressed |
| Ibuprofen | Ibuprofen | 42 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | 11 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 40 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 40 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 39 | suppressed |
| Fluconazole | Fluconazole | 39 | 12 |
| Linzess | Linaclotide | 39 | suppressed |
| Nitroglycerin | Nitroglycerin | 39 | 31 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 22 |
| Solifenacin Succinate | Solifenacin Succinate | 38 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 37 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 36 | 29 |
| Lumigan | Bimatoprost | 35 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 34 | suppressed |
| Verapamil Er | Verapamil Hcl | 34 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 33 | suppressed |
| Cephalexin | Cephalexin | 31 | 23 |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 31 | suppressed |
| Metolazone | Metolazone | 31 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 18 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 30 | suppressed |
| Brilinta | Ticagrelor | 30 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 30 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | 14 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 27 | suppressed |
| Nyamyc | Nystatin | 27 | 12 |
| Diazepam | Diazepam | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 26 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 23 |
| Acetic Acid | Acetic Acid | 24 | suppressed |
| Enulose | Lactulose | 24 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 24 | suppressed |
| Dutasteride | Dutasteride | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 23 | suppressed |
| Risperidone Er | Risperidone Microspheres | 23 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 18 |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | 15 |
| Enoxaparin Sodium | Enoxaparin Sodium | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Lactulose | Lactulose | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 20 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 20 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 19 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 14 |
| Klor-Con M20 | Potassium Chloride | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | 12 |
| Lorazepam Intensol | Lorazepam | 19 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 19 | suppressed |
| Methimazole | Methimazole | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 13 |
| Mupirocin | Mupirocin | 17 | 14 |
| Pregabalin | Pregabalin | 17 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Epinephrine | Epinephrine | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 16 | suppressed |
| Novolog | Insulin Aspart | 16 | suppressed |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 14 | 14 |
| Atomoxetine Hcl | Atomoxetine Hcl | 14 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 14 | 13 |
| Restasis Multidose | Cyclosporine | 14 | suppressed |
| Travoprost | Travoprost | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 13 | suppressed |
| Daptomycin | Daptomycin | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 13 | suppressed |
| Nortrel | Norethindrone-Ethin. Estradiol | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $839.08 · 19 records | Novo Nordisk Inc | AMPLATZER, Auvelity, CARDIOMEMS, DUPIXENT, Ozempic, QULIPTA, Rybelsus, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, UBRELVY, VRAYLAR, ZEPBOUND | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error